TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting.

Thomas Pfeiffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.